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Highlights 
 
 Participants were injected with NGF (day 0) and hypertonic saline (day 2). 
 
 Saline-induced pain increases the variation and changes the direction of the force. 
 
 Persistent pain changes force direction from the pain-free direction. 
 
 Supporting the search and consolidation of new motor strategies during pain. 
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ABSTRACT 36 
Musculoskeletal pain is associated with multiple adaptions in movement control. This study 37 
aimed to determine whether changes in movement control acquired during acute pain are 38 
maintained over days of pain exposure. On day-0, the extensor carpi radialis brevis (ECRB) 39 
muscle of healthy participants was injected with nerve growth factor (NGF) to induce persistent 40 
movement-evoked pain (N=13) or isotonic saline as a control (N=13). On day-2, short-lasting 41 
pain was induced by injection of hypertonic saline into ECRB muscles of all participants. Three-42 
dimensional force components were recorded during submaximal isometric wrist extensions on 43 
day-0, day-4, and before, during, and after saline-induced pain on day-2. Standard deviation 44 
(variation of task-related force) and total excursion of center of pressure (variation of force 45 
direction) were assessed. Maximal movement-evoked pain was 3.3±0.4 (0-10 numeric scale) in 46 
the NGF-group on day-2 whereas maximum saline-induced pain was 6.8±0.3 cm (10-cm visual 47 
analogue scale). The difference in centroid position of force direction relative to day-0 was 48 
greater in the NGF-group than controls (P<0.05) on day-2 (before saline-induced pain) and day-49 
4, reflecting changes in tangential force direction used to achieve the task. During saline-induced 50 
pain in both groups, tangential and task-related force variation was greater than before and after 51 
saline-induced pain (P<0.05).  52 
Perspectives 53 
Persistent movement-evoked pain changes force direction from the pain-free direction. Acute 54 
pain leads to increase variation in force direction irrespective of persistent movement-evoked 55 
pain preceding the acutely painful event. These differences provide novel insight into the search 56 
and consolidation of new motor strategies in the presence of pain. 57 
Key words: Force, NGF, muscle pain, persistent pain. 58 
  59 
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INTRODUCTION 60 
Transient muscle pain is accompanied by changes in movement patterns
2,17,32
 and is thought to 61 
serve a protective function to reduce threat to the painful/injured region. Resolution of pain is not 62 
necessarily associated with a return to the original motor pattern.
17,43
 One hypothesis is that 63 
movement changes during pain are achieved by an initial increase in variation to search for a 64 
new strategy, and once a beneficial strategy is found, variation is reduced to maintain the new 65 
strategy.
27
 Motor adaptations may be maintained for the duration of pain, or continue to undergo 66 
change if pain persists. 67 
Transient muscle pain induced by hypertonic saline injection changes coordination 68 
between muscles
12,16
 and the spatial distribution of activation within a muscle.
18,23
 The principal 69 
interpretation of altered muscle activity is to reduce the potential for further pain and tissue 70 
damage.
17,22
 Noxious input also increases variability in force during submaximal isometric 71 
contractions in both the primary direction of task-related force
2
 and in directions tangential to the 72 
primary task force.
25,32
 Increased variation in different directions could have different 73 
interpretations. Variation in the tangential force could represent a search for less 74 
painful/threatening directions that redistribute load across painful structures.
17
 In the primary 75 
task-related force direction increased variation is unlikely to represent a search for a new strategy 76 
as this would compromise the goal to maintain a target force, instead it might be the result of to 77 
the purposeful variation in tangential force or result from interference by pain secondary to 78 
distraction,
8
 impaired proprioception,
7
 or altered synchronization/recruitment of different 79 
populations of motor units.
24,41,46
 Although these interpretations appear logical when a person is 80 
first exposed to noxious input, features of the motor adaptation may differ over longer periods. If 81 
pain is sustained it might be expected that the new motor solution would become consolidated, 82 
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and variation would reduce around a new motor solution. How motor adaptations in pain change 83 
over time has received little attention, primarily as a consequence of the lack of suitable 84 
experimental methods that induce suitably prolonged noxious stimulus.  85 
One possibility to induce persistent pain is intramuscular injection of nerve growth factor 86 
(NGF), which induces muscle soreness and movement-evoked pain for several days.
1,4,38,39
 87 
Administration of NGF does not elicit immediate muscle pain
1,30,38,39
 but induces localised 88 
hyperalgesia after several hours that is provoked during function.
1,4,14
 This presents a possible 89 
method to study the time-course of motor adaptation. 90 
This study aimed to compare changes of direction and variation of multidirectional (task-91 
related and tangential) forces: (1) in the presence of acute experimental pain; (2) after 92 
experimental movement-evoked pain had been sustained for several days; and (3) with the 93 
combined effect of additional acute pain on a background of persistent movement-evoked pain. It 94 
was hypothesised that: (1) acute experimental muscle pain would increase variation in the 95 
primary force direction consistent with pain interference, and variation in the force direction 96 
consistent with a search for a less threatening motor pattern, and alter the direction of the 97 
tangential force, but without compromising their ability to maintain the task goal; (2) direction of 98 
tangential force would differ by a greater amount between baseline and follow-up after several 99 
days of persistent movement-evoked pain (maintenance of a new solution), than it would 100 
between days in the absence of pain (3) variation in force direction would not be greater than 101 
baseline after several days of persistent pain as a “search” for a new movement solution would 102 
be expected to have occurred when pain was first experienced, but variation in the task-related 103 
force may continue if interference by pain persisted; and (4) addition of acute pain on persistent 104 
pain would lead to a new search (increased variation) and additional change in direction.  105 
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METHODS 106 
Participants 107 
Twenty-six healthy volunteers (7 females, age: 26 ± 5 years, mean ± standard deviation) 108 
participated in the study. Participants were free of upper limb pain, and had no history of pain or 109 
neuromuscular disorders affecting the upper limb region. All participants received written and 110 
verbal description of the procedures and gave written informed consent. The experimental 111 
procedures were approved by the local ethics committee (N-201200640) and the Declaration of 112 
Helsinki was respected. 113 
 114 
Experimental protocol 115 
Participants sat upright in a height-adjustable chair with their back resting against backrest. The 116 
forearm of the dominant arm was in a pronated position, and the hand formed a fist. The distal 117 
portion of the hand was in slight contact with a force transducer, which recorded the force output 118 
during wrist extension (Fig. 1). The experiment was performed as a randomised, double-blinded, 119 
placebo-controlled design, across 3 sessions (day-0, day-2, and day-4). During the first session 120 
(day-0), participants from the NGF group (N=13; five females) received a single dose of 5 µg 121 
human β-Nerve Growth Factor (0.2 ml, 25 µg/ml, prepared by the pharmacy at Aalborg 122 
University, Hospital), and participants from the Control group received a single dose of sterile 123 
isotonic saline (0.2 ml, 0.9%; N=13; two females), injected into the extensor carpi radialis brevis 124 
(ECRB) muscle. The number of participants included in each group was based on previous 125 
studies using a similar design to evaluate the effects of intramuscular NGF injections.
14,38,39
 All 126 
injections were performed on the dominant side, and injection site and depth was determined by 127 
guidance of ultrasound imaging. The injection site was marked with indelible ink. Participant’s 128 
wrist was also marked in order to ensure consistent alignment of the arm position with the force 129 
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transducer between sessions. Participants performed a series of force-matched wrist extensions 130 
before and after the injection. During the second session (day-2), acute muscle pain was induced 131 
by injection of hypertonic saline (0.5 ml, 5.8%) in the ECRB muscle (same location as NGF/iso 132 
injection) of participants in both groups. Participants performed the motor task before, during, 133 
and after the acute pain experienced by injection of hypertonic saline. Note that at this time point 134 
it was expected that the NGF group would have experienced movement-evoked pain induced by 135 
the NGF injection for multiple days. In the third session (day-4), participants performed one trial 136 
of the motor task without any injection (Fig. 1). 137 
 138 
Motor task 139 
In each session, the maximal voluntary contraction (MVC) was recorded by performing three 140 
consecutive maximal isometric wrist extension trials for 10 s with an interval of 30 s in-between. 141 
The maximum force (calculated in the Fz direction) among the three wrist extension repetitions 142 
was used as the MVC force for the remaining trials and sessions. After a 60-s rest, a set of 143 
submaximal isometric wrist extensions was performed, consisting of 3 consecutive trials at 10% 144 
MVC with a 5-s ascending ramp, 10 s of steady phase, and a 5-s descending ramp. The target 145 
force level and the participant’s actual force in the task-related direction (i.e. in Fz direction) 146 
were presented as lines on a computer screen. Participants matched the target force as precisely 147 
as possible. Tangential forces were recorded during each trial. 148 
 149 
Force and torque recordings 150 
Three-dimensional force components and torques were measured using a six-axis load cell 151 
transducer (MC3A 250, AMTI, USA) with high sensitivity (0.054, 0.054, 0.0134 V/N for Fx, Fy, 152 
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Fz; and 2.744, 2.744, 2.124 V/Nm for Mx, My, Mz). The analogue outputs of the transducer 153 
were amplified and low-pass filtered at 1 kHz (MSA-6, AMTI, USA). The force and torque 154 
signals were sampled at 2 kHz and stored after 12-bit A/D conversion. 155 
 156 
Pain intensity assessment  157 
Participants completed a pain questionnaire in the evening of each session day. The 158 
questionnaire consisted of three questions relating to their pain quantified used an 11-point 159 
numerical rating scale (NRS) where 0 = ‘no pain’ and 10 = ‘worst pain imaginable’. Pain 160 
intensity was reported: “at rest”, while performing a task involving “repeated wrist 161 
extension/flexion and elbow flexion/extension movements in daily life activities” in the previous 48 162 
hours, and the “maximum pain that had been experienced in the previous 48 hours”. Following 163 
the hypertonic saline injection, pain intensity was scored continuously until pain resolution, on a 164 
10-cm electronic visual analogue scale (VAS) where 0 cm indicated ‘no pain’ and 10 cm ‘worst 165 
pain imaginable’. The peak VAS score following the injection was extracted for further analysis.  166 
 167 
Data analysis 168 
Force and torque signals were digitally low-pass filtered at 20 Hz using a second order 169 
Butterworth filter. In order to avoid regions within the force trace that may be associated with 170 
slow force development and anticipation to the decreasing force phase of the task, 8 s in the 171 
middle of the steady period of force maintenance was selected for data analysis. Standard 172 
deviation (SD) was used to quantify force variability in the task-related direction. Force error 173 
was calculated using the residual sum of squares error (RSS) of the force trace from the target 174 
line, reflecting the force accuracy in the Fz direction. The total excursion of the centre of 175 
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pressure (CoP) was used to quantify lateral shifts of the quasi-static net force (i.e. changes in 176 
force direction). This index reflects the total length of the CoP path in a given time period
29
 and 177 
represents an indirect measure of the tangential force variation.
26,32,33
 A two-dimensional 178 
histogram of tangential force components was developed using a 5-by-5 equally spaced grid to 179 
represent the range of the force in the Fy (wrist radial-ulnar deviation) and Fx (longitudinal 180 
movement of the wrist) direction. Coordinates of the centroid were extracted from the force 181 
histogram. For the analysis of the effect of persistent pain, the centroid position at day-2 and at 182 
day-4 was subtracted from the position of the centroid obtained during baseline day-0 for both 183 
groups. For saline-induced muscle pain, centroid position during and after saline-induced pain 184 
was subtracted from the baseline (before saline-induced pain trial) at the same day (day-2). To 185 
provide a “no-pain” measure of the change in centroid position against which the hypertonic 186 
saline conditions could be compared, we subtracted the centroid position prior to saline induced 187 
pain on day-2 from the centroid position prior to isotonic saline injection on day-0, for the 188 
Control group. The absolute difference in Fy and Fx directions were extracted (Fy and Fx, 189 
respectively). A centroid position difference (Fx-CPD and Fy-CPD) value deviating from zero 190 
indicates that new combinations of tangential forces were used in that condition reflecting 191 
changes the direction of the net force.
15,25
 Thus, CoP quantifies variability of the force direction, 192 
whereas CPD represents magnitude of change in the direction of the force between two trials. 193 
 194 
Statistical analysis 195 
SD of the force (Fz) and excursion of the CoP were normalised for each injection type. To 196 
reduce the between-subject variability of the samples,
37
 normalisation was implemented by 197 
dividing parameters of each participant with their peak value across trials (Baseline day-0, 198 
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Baseline day-2 [before saline-induced pain], and Baseline day-4 for NGF/isotonic saline 199 
injection; and before, during, and after saline-induced pain for hypertonic saline injection).  200 
Effects of saline-induced pain: To test the first hypothesis whether force variation in the 201 
tangential direction (excursion of CoP), and/or variation (SD of Fz) and error (Fz RSS) in the 202 
primary task direction were altered by saline-induced muscle pain on day-2, a repeated measures 203 
analysis of variance (ANOVA) was applied using Time (before, during, and after saline-induced 204 
muscle pain) as a within-subject factor for the Control group. This analysis did not include the 205 
NGF group who received saline injection in addition to NGF. To test whether force direction is 206 
altered by saline-induced pain on day-2, CPD were analysed using a repeated measures ANOVA 207 
with Time (Baseline [pre-injection day-0 minus pre-injection day-2], during saline-induced pain 208 
[pre-pain minus pain], and after [post-pain minus pain]) as a within-subject factor.  209 
Effects of injection of NGF and isotonic saline: To test hypotheses 2 and 3, whether force 210 
direction variation (excursion of CoP), and/or variation (SD of Fz) and error (Fz RSS) in the 211 
primary task direction were modified after several days of sustained pain following NGF 212 
injections; these data were analysed using a mixed-model design ANOVA with Group (NGF and 213 
isotonic saline) as a between-subject factor, and Session (day-0, day-2 before-saline injection, 214 
and day-4) as a within-subject factor. To test whether tangential force direction is altered by 215 
persistent pain, CPD were analysed using a mixed-model ANOVA with Group (NGF and 216 
isotonic saline) as a between-subject factor and Session (day-2 before-saline injection minus pre-217 
injection day-0 and day-4 minus pre-injection day-0) as a within-subject factor. Newman–Keuls 218 
(NK) post-hoc tests were applied in case of significant effects from main factors or interactions. 219 
We also compared maximum force between sessions to investigate whether this was constant 220 
across days. 221 
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Effects of saline-induced pain during persistent movement-evoked pain: To test hypothesis 222 
4, whether  variation in the force direction (excursion of CoP), and/or variation (SD of Fz) and 223 
error (Fz RSS) in the primary task direction were altered by saline-induced muscle pain during 224 
movement-evoked pain on day-2, a repeated measures analysis of variance (ANOVA) was 225 
applied using Time (before, during, and after saline-induced muscle pain) as a within-subject 226 
factor for the NGF group. CPD were analysed using a repeated measures ANOVA with Time 227 
(Baseline [pre-injection day-0 minus pre-injection day-2], during saline-induced pain [pre-pain 228 
minus pain], and after [post-pain minus pain]) as a within-subject factor.  229 
As peak VAS scores and data from the pain questionnaire were not normally distributed, 230 
Mann-Whitney U tests were used to assess differences between groups (before, during, and after 231 
saline-induced pain for peak VAS scores, and day-0, day-2, and day-4 for pain questionnaire 232 
measures, respectively). The Wilcoxon Signed Rank test was used to analyse for differences 233 
between sessions within a group across time trials (VAS scores) and days (pain questionnaire, 234 
measures were analysed individually), and Bonferroni corrections were used to adjust P-values 235 
for multiple comparisons. Data are presented as magnitude of relevant difference in the results 236 
section, and mean and standard error of the mean (SEM) throughout the tables and figures. P-237 
values less than 0.05 were regarded as significant. 238 
 239 
RESULTS 240 
Pain  241 
Participants injected with NGF reported greater NRS pain scores when performing “repeated arm 242 
movements” on day-2 (2.6/10) and day-4 (1.6/10) than those injected with isotonic saline (Table 243 
1, Z=3.3, P<0.001). The NGF group also reported greater “maximum pain experienced over the 244 
past 48 hours” on day-2 (2.7/10) and day-4 (2.1/10) than day-0 (Z=3.05, P<0.002), and the 245 
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highest “maximum pain experienced over the past 48 hours” was reported on day-2 (0.9/10) 246 
(Z=3.17, P<0.001). There was no significant difference in NRS pain scores “at rest” between 247 
groups.  248 
The NGF group reported higher VAS scores before (1.04/10) and after (0.58/10) saline-249 
induced pain than the control group (Z=4.46, P<0.001), although these difference in the levels of 250 
pain might not be considered as clinically relevant. Both groups reported higher VAS scores 251 
during saline-induced pain than before and after saline-induced pain (6.23/10) (Table 2, Z=4.45, 252 
P<0.001). VAS scores did not differ between groups during saline-induced pain (Z=1.64, 253 
P=0.09). 254 
 255 
Effect of saline-induced pain (control group) 256 
Comparison of force between trials performed before, during, and after saline-induced pain on 257 
day-2 for the control group showed that variation was increased in the primary task-direction 258 
during acute pain (0.11/1) (SD of Fz; ANOVA: F(2,24)=3.52; P<0.05; NK: P<0.05) consistent 259 
with a decrease in motor performance during pain (Fig. 2A). Variation of the force direction was 260 
also greater (0.18/1) (CoP excursion; ANOVA: F(2,21)=4.44, P=0.023; NK: P<0.005) during 261 
acute pain compared with before and after trials (Fig. 2A). This shows that increased variation of 262 
force in directions other than the task-direction, which is consistent with a search for a new 263 
solution. There was no significant difference in force error (Fz RSS) during saline-induced pain 264 
(ANOVA: F(2,22)=1.29; P>0.15; Fig. 2B) indicating that despite the increase in variation they 265 
could maintain the level of force. 266 
In the Control group, CPD in the Fy direction (wrist radial-ulnar deviation) during saline-267 
induced pain (contrast between measures made on day-2 during and before saline-induced pain) 268 
was greater than the contrast between measures made before injections on day-2 and day-0 (as an 269 
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estimate of CPD expected between sessions in the absence of pain) and after saline-induced pain 270 
(contrast between measures made on day-2 after and before saline-induced pain) (0.28/5) 271 
(ANOVA: F(2,22)=9.35; P<0.001; NK: P<0.02; Fig. 3 and Table 3). This shows a greater change 272 
in force direction when challenged by saline-induced muscle pain than would be expected 273 
between sessions without pain.  274 
 275 
Effect of prolonged movement-evoked pain on the direction of the force 276 
CPD (contrast of measures made on day-2 before saline-induced pain and day-0, and the contrast 277 
between measures made on day-4 and day-0) in the Fy direction (wrist radial-ulnar deviation) 278 
was greater in the NGF than control group (0.12/5) (ANOVA: F(1,22)=4.26; P<0.05; NK: P<0.05; 279 
Fig. 3). This shows that persistent pain involves a new task “solution” as indicated by the 280 
modification of the combination of forces used to achieve the task goal.  281 
 282 
Effect of prolonged movement-evoked pain on the variation of the force 283 
Comparison of contraction force between trials performed before injection of NGF, day-2 284 
(before saline-induced pain), and day-4 showed no difference in variation in the primary task-285 
direction (SD of Fz; F2,42=1.87, P=0.15) and variation of the direction (CoP excursion; 286 
F1,42=1.11, P=0.30; Fig. 4A). This finding shows that there is no on-going increase in force 287 
variation (i.e. no on-going “search”) in the presence of persistent pain. The force error (Fz RSS) 288 
(ANOVA: F(1,22)=2.20; P=0.15; Fig. 4C) and the MVC in the task-related direction (ANOVA: 289 
F(2,22)=2.31; P=0.10; Fig. 4D) were not affected significantly by persistent movement-evoked 290 
pain, indicating that they could maintain the level of force despite the modified force direction. 291 
 292 
Effect of saline-induced acute pain during prolonged movement-evoked pain 293 
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Comparison of contraction force for wrist extension performed before, during and after saline-294 
induced pain on day-2 for the NGF group showed greater variation in the task-related direction 295 
(0.15/1) (SD of Fz; ANOVA: F(2,22)=4.42; P<0.05) and in the variation of the force direction 296 
(0.19/1) (CoP excursion; ANOVA: F(2,10)=11.10, P<0.005; NK: P<0.005) during acute pain.  297 
When saline-induced pain was added to the movement-evoked pain induced by NGF 298 
injection, the CPD in the Fy direction calculated using the contrast of measures made on day-2 299 
during and day-2 before saline-induced pain (i.e. effect of saline induced pain) was greater than 300 
the contrast of day-2 before saline-induced pain and day-0 (i.e. effect of persistent pain) (0.25/5) 301 
(ANOVA: F(1,24)=13.55; P=0.001; NK: P=0.001). In the presence of persistent pain, participants 302 
retained the capacity to adapt in the same manner (increase variation in the force direction and 303 
change force direction) as participants who had no persistent pain. 304 
 305 
DISCUSSION  306 
These results show that saline-induced acute muscle pain increases variation in the task-related 307 
force and changes the variation and direction of the forces, but without affecting the ability to 308 
achieve the task goal. When people are assessed after a period of persistent pain the force 309 
direction differs from baseline, but with no difference in variation. These findings can be 310 
interpreted according to contemporary theories of motor adaptation and are likely to represent 311 
different elements of the search and then consolidation of a new, potentially more protective 312 
solution, while maintain the capacity to achieve the task goal. 313 
 314 
Pain during hypertonic saline and NGF injection 315 
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The two pain models used in this study induced pain with different intensities, qualities and pain 316 
duration profiles. These were selected to study the impact of short-term acute pain and persistent 317 
movement-evoked pain on motor control strategies. Participants receiving NGF injections 318 
reported soreness and pain evoked by arm movement in the days following the injection, but not 319 
immediately after injection and minimal or no pain at rest (no spontaneous pain). Although the 320 
mechanism underlying the pain response following NGF injection remains unclear, it has been 321 
suggested to involve sensitization of nociceptors without inducing spontaneous discharge.
28,34
 322 
The intensity and duration of movement-evoked pain by administration of NGF provides a useful 323 
model to study effects of prolonged pain. Intramuscular injection of hypertonic saline induced 324 
spontaneous and transient muscle pain in both groups that lasted a few minutes. Saline-induced 325 
pain has been associated with robust excitation of the nociceptive afferent fibres
13,20
 but is not 326 
clearly related to movement/muscle activation.
40
 The lack of difference in the intensity of pain 327 
induced by hypertonic saline injection between groups has several interpretations. First, 328 
sensitisation of nociceptive neurons by NGF may not enhance their responsiveness to hypertonic 329 
saline. Second, that the hypertonic saline may not have excited the same population of 330 
nociceptive neurons that were sensitised by NGF (injection in a slightly different location). 331 
Comparable pain intensity has been reported during saline-induced pain between muscles with 332 
and without sensitisation by eccentric exercise.
11,36,45
 Similar results have been observed in 333 
glutamate-evoked pain in participants with and without injection of NGF in the masseter 334 
muscle.
39
 335 
 336 
Changes in isometric wrist extension force with pain 337 
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Variation of the task-related and tangential force direction was increased during saline-induced 338 
muscle pain for both groups (i.e. irrespective of whether there was an underlying persistent pain). 339 
This concurs with previous findings of the effect of acute muscle pain on the force variation for 340 
isometric shoulder-abduction,
2
 elbow flexion,
25,32
 knee extension
31
, and dorsiflexion.
32
  341 
Increased variation in the task-related direction may represent a detrimental effect of pain 342 
mediated by several possible mechanisms. Experimental muscle pain decreases the ability of 343 
central nervous system to process proprioceptive information,
7
 and alters the population of 344 
recruited motor units,
9,41
 each of which may impact the capacity of the muscle to maintain 345 
constant force. It is important to note that although the quality of the motor tasks was 346 
compromise, they could still achieve the task goal (no change in task error). Although the 347 
increase in variation of the tangential direction may also represent a similar mechanism, it may 348 
also serve a purpose; to aid the search for a new less provocative solution (see below). 349 
NGF-induced muscle soreness (without the addition of hypertonic saline injection) was not 350 
associated with more force variation than baseline (day-0) when tested after pain had been 351 
experienced for 2 and 4 days. This implies that in this model of slowly increasing movement-352 
evoked pain there is either no change in variation or that there is an initial increased in variation, 353 
that resolves when pain is maintained. This latter possibility is consistent with previous findings 354 
demonstrating that force variability is only affected for a few hours after the onset of muscle 355 
soreness induced by eccentric exercise although maximal force is reduced for several days in that 356 
model.
21,35
  357 
Immediate motor adaptations to acute nociceptive input are task dependent,
5,17,25
 whereas 358 
the effects of persistent pain remain unclear. From our study it is not possible to determine 359 
whether soreness and movement-evoked pain induced by NGF was associated with greater 360 
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variation of the forces in the primary task direction or tangential directions at the onset of pain 361 
provocation as participants were not tested until 2 days after the injection. Despite this, the data 362 
show convincing evidence of isometric wrist extension with different direction of tangential 363 
forces, but with unchanged variation in force in any direction, after several days with pain. This 364 
corroborates the hypothesis that motor adaptations are consolidated over time, that is, although 365 
an initial increase in variation may have facilitated a search for a new solution, when pain is 366 
persistent and a new solution is identified, variation returns to baseline levels. Changes in the 367 
force direction during experimental pain has been found in previous studies
32,42
 and it has been 368 
suggested that this strategy aims to reduce pain further and potential tissue damage.
17,42
 Even 369 
slight altered direction of the force represents a great impact on the efficiency of the mechanical 370 
system during pain.
42
 371 
 372 
Factors involved in the consolidation of motor adaptations over time 373 
The motor system enables people to perform daily activities using pre-learned motor strategies, 374 
acquired by repetition, failure and success in previous experiences.
3
 Using fMRI, it has been 375 
shown that the extent of cortical activation increases in healthy subjects when learning an 376 
untrained motor skill for 2 weeks
44
 and then decreases with further training. This adaptation is 377 
thought to relate to the initial exploration and heightened attention to perform the new task 378 
during training, followed by the consolidation of a new strategy. Thus, the motor system need to 379 
explore for a strategy that satisfies the new requirements, and increasing the tangential force 380 
variation may facilitate the searching in acute pain.
27
 381 
High precision force-matching tasks are an unfamiliar motor activity, and most likely 382 
require participants to focus their attention during performance. Results from chronic pain 383 
18 
 
patients have shown that those who report high pain intensities have reduced attention when 384 
performing complex motor tasks than those with low pain and controls.
8
 Distraction due to high-385 
pain intensity could account for the increased variation in the force during saline-induced pain.  386 
Motor adaptations induced by soreness and movement-evoked pain lasted for several days. 387 
The adaptations caused by persistent pain are observed as reorganisation of the tangential force 388 
to perform the motor task sustained across days. There was a non-significant tendency for greater 389 
changes in the tangential force combination at day 4 than day 2, even though peak soreness and 390 
pain were reported at day 2. This means that participants who received NGF injection continued 391 
to display protective behaviours even when persistent pain had begun to resolve. It has been 392 
suggested that the anticipation to experience pain, rather than pain itself, might account for the 393 
sustained pain adaptations in chronic pain patients.
10
 Moreover, pain has been described as a 394 
“motivator” for motor adaptation, but pain cessation does not necessarily motivate a return to the 395 
pre-pain pattern.
17
 Whether the force recovered after the resolution of the sustained pain was not 396 
studied in this experiment, but should be considered in future work. 397 
There is debate whether pain interferes with learning a motor skill. Although some data 398 
show reduced adaptation of cortical excitability during learning in the presence of pain,
6
 when 399 
the quality of practice of the task is controlled, there is no interference.
19
 Thus, pain may not 400 
compromise learning, but appears to lead to the learning of a different task such as an adaptation 401 
to alter the motor strategy used to achieve the goal of the motor task during pain.
17
 The present 402 
results showed that participants with persistent pain retained the new strategy (potentially a 403 
protective behaviour) across sessions.  404 
Interpretation of the present findings requires consideration of several limitations. First, the 405 
current findings are limited to steady force control during low level of isometric wrist extensions, 406 
19 
 
and do not necessarily generalize to other types of contractions relevant to functional activities, 407 
such as, for example, dynamic force control during concentric/eccentric contractions or higher 408 
level of contractions. Second, the data was collected in confined time intervals and the motor 409 
adaptations were not constantly monitored following NGF injection, so learning and 410 
consolidation of a new motor strategy is assumed from the results. However, because of the 411 
specificity of the assessed motor task and for practical reasons, it was not possible to perform a 412 
continuous assessment of the motor task. Therefore, changes in the movement pattern for daily 413 
activities at times between the data collection sessions, including isometric wrist extensions, 414 
remain unknown. Third, changes in the arm position between trials might affect the CoP, 415 
although SD Fz and CPD indexes are not affected by the reposition of the arm. To reduce this 416 
error, participants’ wrist was marked facilitating the same position between trials. Fourth, the 417 
number of female participants was not balanced between groups. A previous study showed no 418 
gender difference in NGF evoked sensitization, although hypertonic saline superimposed to NGF 419 
elicited higher pain in males than females.
1
 Gender comparison between groups during 420 
hypertonic saline was not performed and it was beyond the scope of this study because of the 421 
sample size.  422 
CONCLUSION 423 
Acute pain increases force variation and changes the force direction, but when pain is sustained 424 
only the force direction differs from that in a pain-free state. These differences imply different 425 
elements of learning a new motor strategy in the presence of pain; an initial “search” for a 426 
beneficial solution mediated by increased variation, and a later “consolidation” to the new 427 
alternative. In a clinical context if pain is sustained, treatments that target pain relief might 428 
20 
 
require additional intervention that targets changes in motor performance to restore the pain-free 429 
optimal control of the task.   430 
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FIGURE LEGENDS 558 
 559 
Fig. 1. Experimental setup and protocol. Upper panel: Wrist extension force was recorded in the 560 
task-related (Z) and the tangential (X and Y) directions using a three-dimensional force 561 
transducer. Marks on the wrist and on the force transducer were used to replace the arm in the 562 
same position at each session. Lower panel: Time-course of the experimental protocol. On day-0, 563 
the extensor carpi radialis brevis muscle (dominant arm) of twenty-six healthy volunteers was 564 
injected with nerve growth factor (NGF, N=13) or isotonic saline (ISO, N=13). On day-2, acute 565 
experimental muscle pain was induced by injection of hypertonic saline into the extensor carpi 566 
radialis brevis muscle (same side as the first injection) of all participants. 567 
 568 
Fig. 2. Normalised mean (±SEM, N=13) (A) standard deviation (SD) of task-related force and 569 
(B) excursion of the centre of pressure for tangential forces (CoP) during the steady contraction 570 
period (wrist extension at 10% maximal voluntary contraction force) for saline-induced pain. 571 
Significantly increased during saline-induced pain compared with before and after saline-induced 572 
pain sessions (*, P<0.05). (C) Normalised mean (±SEM, N=13) residual sum of squares error 573 
(RSS) in the task-related (Fz) direction before, during, and after saline-induced pain. 574 
 575 
Fig. 3. Distribution of centroid position difference (CPD) of the tangential forces (Fx and Fy). 576 
Data are shown for the Control group in the absence of pain (contrast between baseline day-0 577 
and baseline day-2; far left, upper panel) and for the NGF group after 2 days of pain (contrast 578 
between measures before NGF injection on day-0 and before saline injection day 2; far left, 579 
lower panel). Subsequent panels show CPD for both groups during and after saline-induced pain 580 
27 
 
(contrasted to before saline-induced pain) on day-2, and on day-4 (contrast between baseline 581 
day-0 and day-4; far right panel). Both groups showed greater CPD (spread of the colours) in the 582 
Fy direction (P<0.001) when challenged with saline-induced pain compared with the baseline 583 
condition. This reflects greater changes in the direction of tangential force used to achieve the 584 
motor task. The NGF group showed greater CPD than the control group across days in the Fy 585 
direction (P<0.05), i.e. NGF group deviate from the baseline direction of tangential force across 586 
days. 587 
 588 
Fig. 4. Normalised mean (±SEM, N=13) (A) standard deviation (SD) of task-related force and 589 
(B) excursion of the centre of pressure for tangential forces (CoP) during the steady contraction 590 
period (wrist extension at 10% MVC force) across days (day-0, baseline day-2, day-4) for 591 
persistent movement-evoked pain (NGF) and controls. (C) Normalised mean (±SEM, N=13) 592 
residual sum of squares error (RSS) in the task-related (Fz) direction. (D) Maximal voluntary 593 
contraction (MVC) force in the task-related direction (Fz) across days. 594 
 595 
TABLES 
 
 
Table 1 Pain intensity (mean±SEM) reported on numerical rating scale related to nerve 
growth factor injection 
 
 Pain at rest 
Pain during repeated 
arm movement 
Worst pain in past 48 
hours 
NGF group 
Day-0 0 ± 0 0 ± 0 0 ± 0 
Day-2 0.31 ± 0.24 2.69 ± 0.36*
#
 3.31 ± 0.40*
#
 
Day-4 0.15 ± 0.10 1.61 ± 0.33*
#
 2.38 ± 0.50*
#
 
Control group 
Day-0 0 ± 0 0 ± 0 0 ± 0 
Day-2 0 ± 0 0.08 ± 0.08 0.61 ± 0.21 
Day-4 0 ± 0 0 ± 0 0.23 ± 0.17 
* - NGF group reported higher pain on the NRS on day-2 and day-4 than the control group 
(P<0.001).  
# - NGF group reported higher pain on the NRS on day-2 and day-4 than Day-0 (P<0.01). 
  
Tables
Table 2 Pain intensity (mean±SEM) reported on visual analogue scale related to hypertonic 
saline injection 
 
 Before  During saline-induced pain After  
NGF group 1.04 ± 0.38
#
 7.27 ± 0.43* 0.58 ± 0.3
#
 
Control group 0 ± 0 6.23 ± 0.33* 0 ± 0 
* - Higher VAS scores during the saline-induced pain than before and after saline-induced pain trials 
(P<0.001).  
# - NGF group reporter higher VAS scores than the Control group (P<0.05). 
  
 
Table 3 
Centroid position difference  
Fy direction 
 Day-2 Day-4 
 Baseline 
During saline-
induced pain 
After saline-
induced pain 
 
NGF group 0.25 ± 0.05* 0.62 ± 0.09
#
 0.39 ± 0.08 0.45 ± 0.06* 
Control group 0.18 ± 0.05 0.45 ± 0.08
#
 0.31 ± 0.08 0.24 ± 0.06 
Fx direction 
NGF group 0.41 ± 0.07 0.21 ± 0.06 0.26 ± 0.08 0.28 ± 0.07 
Control group 0.31 ± 0.07 0.30 ± 0.06 0.35 ± 0.08 0.41± 0.07 
Mean (±SEM, N=13) of the absolute centroid position difference (CPD) of the Fx-Fy plane at baseline 
(contrast before saline-induced pain day-2 with day-0), during and after saline-induced pain (contrasting 
each trial with before saline-induced pain day-2), and day-4 (contrast day-4 with day-0). The NGF group 
showed greater (CDP) compared with the control group (*, NK: P=0.048). Significantly increased during 
saline-induced pain compared with baseline and after saline-induced pain sessions (#, P<0.001). 
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ABSTRACT 31 
Musculoskeletal pain is associated with multiple adaptions in movement control. This study 32 
aimed to determine whether changes in movement control acquired during acute pain are 33 
maintained over days of pain exposure. On day-0, the extensor carpi radialis brevis (ECRB) 34 
muscle of healthy participants was injected with nerve growth factor (NGF) to induce persistent 35 
movement-evoked pain (N=13) or isotonic saline as a control (N=13). On day-2, short-lasting 36 
pain was induced by injection of hypertonic saline into ECRB muscles of all participants. Three-37 
dimensional force components were recorded during submaximal isometric wrist extensions on 38 
day-0, day-4, and before, during, and after saline-induced pain on day-2. Standard deviation 39 
(variation of task-related force) and total excursion of center of pressure (variation of force 40 
direction) were assessed. Maximal movement-evoked pain was 3.3±0.4 (0-10 numeric scale) in 41 
the NGF-group on day-2 whereas maximum saline-induced pain was 6.8±0.3 cm (10-cm visual 42 
analogue scale). The difference in centroid position of force direction relative to day-0 was 43 
greater in the NGF-group than controls (P<0.05) on day-2 (before saline-induced pain) and day-44 
4, reflecting changes in tangential force direction used to achieve the task. During saline-induced 45 
pain in both groups, tangential and task-related force variation was greater than before and after 46 
saline-induced pain (P<0.05).  47 
Perspectives 48 
Persistent movement-evoked pain changes force direction from the pain-free direction. Acute 49 
pain leads to increase variation in force direction irrespective of persistent movement-evoked 50 
pain preceding the acutely painful event. These differences provide novel insight into the search 51 
and consolidation of new motor strategies in the presence of pain. 52 
Key words: Force, NGF, muscle pain, persistent pain. 53 
  54 
INTRODUCTION 55 
Transient muscle pain is accompanied by changes in movement patterns
2,17,32
 and is thought to 56 
serve a protective function to reduce threat to the painful/injured region. Resolution of pain is not 57 
necessarily associated with a return to the original motor pattern.
17,43
 One hypothesis is that 58 
movement changes during pain are achieved by an initial increase in variation to search for a 59 
new strategy, and once a beneficial strategy is found, variation is reduced to maintain the new 60 
strategy.
27
 Motor adaptations may be maintained for the duration of pain, or continue to undergo 61 
change if pain persists. 62 
Transient muscle pain induced by hypertonic saline injection changes coordination 63 
between muscles
12,16
 and the spatial distribution of activation within a muscle.
18,23
 The principal 64 
interpretation of altered muscle activity is to reduce the potential for further pain and tissue 65 
damage.
17,22
 Noxious input also increases variability in force during submaximal isometric 66 
contractions in both the primary direction of task-related force
2
 and in directions tangential to the 67 
primary task force.
25,32
 Increased variation in different directions could have different 68 
interpretations. Variation in the tangential force could represent a search for less 69 
painful/threatening directions that redistribute load across painful structures.
17
 In the primary 70 
task-related force direction increased variation is unlikely to represent a search for a new strategy 71 
as this would compromise the goal to maintain a target force, instead it might be the result of to 72 
the purposeful variation in tangential force or result from interference by pain secondary to 73 
distraction,
8
 impaired proprioception,
7
 or altered synchronization/recruitment of different 74 
populations of motor units.
24,41,46
 Although these interpretations appear logical when a person is 75 
first exposed to noxious input, features of the motor adaptation may differ over longer periods. If 76 
pain is sustained it might be expected that the new motor solution would become consolidated, 77 
and variation would reduce around a new motor solution. How motor adaptations in pain change 78 
over time has received little attention, primarily as a consequence of the lack of suitable 79 
experimental methods that induce suitably prolonged noxious stimulus.  80 
One possibility to induce persistent pain is intramuscular injection of nerve growth factor 81 
(NGF), which induces muscle soreness and movement-evoked pain for several days.
1,4,38,39
 82 
Administration of NGF does not elicit immediate muscle pain
1,30,38,39
 but induces localised 83 
hyperalgesia after several hours that is provoked during function.
1,4,14
 This presents a possible 84 
method to study the time-course of motor adaptation. 85 
This study aimed to compare changes of direction and variation of multidirectional (task-86 
related and tangential) forces: (1) in the presence of acute experimental pain; (2) after 87 
experimental movement-evoked pain had been sustained for several days; and (3) with the 88 
combined effect of additional acute pain on a background of persistent movement-evoked pain. It 89 
was hypothesised that: (1) acute experimental muscle pain would increase variation in the 90 
primary force direction consistent with pain interference, and variation in the force direction 91 
consistent with a search for a less threatening motor pattern, and alter the direction of the 92 
tangential force, but without compromising their ability to maintain the task goal; (2) direction of 93 
tangential force would differ by a greater amount between baseline and follow-up after several 94 
days of persistent movement-evoked pain (maintenance of a new solution), than it would 95 
between days in the absence of pain (3) variation in force direction would not be greater than 96 
baseline after several days of persistent pain as a “search” for a new movement solution would 97 
be expected to have occurred when pain was first experienced, but variation in the task-related 98 
force may continue if interference by pain persisted; and (4) addition of acute pain on persistent 99 
pain would lead to a new search (increased variation) and additional change in direction.  100 
METHODS 101 
Participants 102 
Twenty-six healthy volunteers (7 females, age: 26 ± 5 years, mean ± standard deviation) 103 
participated in the study. Participants were free of upper limb pain, and had no history of pain or 104 
neuromuscular disorders affecting the upper limb region. All participants received written and 105 
verbal description of the procedures and gave written informed consent. The experimental 106 
procedures were approved by the local ethics committee (N-201200640) and the Declaration of 107 
Helsinki was respected. 108 
 109 
Experimental protocol 110 
Participants sat upright in a height-adjustable chair with their back resting against backrest. The 111 
forearm of the dominant arm was in a pronated position, and the hand formed a fist. The distal 112 
portion of the hand was in slight contact with a force transducer, which recorded the force output 113 
during wrist extension (Fig. 1). The experiment was performed as a randomised, double-blinded, 114 
placebo-controlled design, across 3 sessions (day-0, day-2, and day-4). During the first session 115 
(day-0), participants from the NGF group (N=13; five females) received a single dose of 5 µg 116 
human β-Nerve Growth Factor (0.2 ml, 25 µg/ml, prepared by the pharmacy at Aalborg 117 
University, Hospital), and participants from the Control group received a single dose of sterile 118 
isotonic saline (0.2 ml, 0.9%; N=13; two females), injected into the extensor carpi radialis brevis 119 
(ECRB) muscle. The number of participants included in each group was based on previous 120 
studies using a similar design to evaluate the effects of intramuscular NGF injections.
14,38,39
 All 121 
injections were performed on the dominant side, and injection site and depth was determined by 122 
guidance of ultrasound imaging. The injection site was marked with indelible ink. Participant’s 123 
wrist was also marked in order to ensure consistent alignment of the arm position with the force 124 
transducer between sessions. Participants performed a series of force-matched wrist extensions 125 
before and after the injection. During the second session (day-2), acute muscle pain was induced 126 
by injection of hypertonic saline (0.5 ml, 5.8%) in the ECRB muscle (same location as NGF/iso 127 
injection) of participants in both groups. Participants performed the motor task before, during, 128 
and after the acute pain experienced by injection of hypertonic saline. Note that at this time point 129 
it was expected that the NGF group would have experienced movement-evoked pain induced by 130 
the NGF injection for multiple days. In the third session (day-4), participants performed one trial 131 
of the motor task without any injection (Fig. 1). 132 
 133 
Motor task 134 
In each session, the maximal voluntary contraction (MVC) was recorded by performing three 135 
consecutive maximal isometric wrist extension trials for 10 s with an interval of 30 s in-between. 136 
The maximum force (calculated in the Fz direction) among the three wrist extension repetitions 137 
was used as the MVC force for the remaining trials and sessions. After a 60-s rest, a set of 138 
submaximal isometric wrist extensions was performed, consisting of 3 consecutive trials at 10% 139 
MVC with a 5-s ascending ramp, 10 s of steady phase, and a 5-s descending ramp. The target 140 
force level and the participant’s actual force in the task-related direction (i.e. in Fz direction) 141 
were presented as lines on a computer screen. Participants matched the target force as precisely 142 
as possible. Tangential forces were recorded during each trial. 143 
 144 
Force and torque recordings 145 
Three-dimensional force components and torques were measured using a six-axis load cell 146 
transducer (MC3A 250, AMTI, USA) with high sensitivity (0.054, 0.054, 0.0134 V/N for Fx, Fy, 147 
Fz; and 2.744, 2.744, 2.124 V/Nm for Mx, My, Mz). The analogue outputs of the transducer 148 
were amplified and low-pass filtered at 1 kHz (MSA-6, AMTI, USA). The force and torque 149 
signals were sampled at 2 kHz and stored after 12-bit A/D conversion. 150 
 151 
Pain intensity assessment  152 
Participants completed a pain questionnaire in the evening of each session day. The 153 
questionnaire consisted of three questions relating to their pain quantified used an 11-point 154 
numerical rating scale (NRS) where 0 = ‘no pain’ and 10 = ‘worst pain imaginable’. Pain 155 
intensity was reported: “at rest”, while performing a task involving “repeated wrist 156 
extension/flexion and elbow flexion/extension movements in daily life activities” in the previous 48 157 
hours, and the “maximum pain that had been experienced in the previous 48 hours”. Following 158 
the hypertonic saline injection, pain intensity was scored continuously until pain resolution, on a 159 
10-cm electronic visual analogue scale (VAS) where 0 cm indicated ‘no pain’ and 10 cm ‘worst 160 
pain imaginable’. The peak VAS score following the injection was extracted for further analysis.  161 
 162 
Data analysis 163 
Force and torque signals were digitally low-pass filtered at 20 Hz using a second order 164 
Butterworth filter. In order to avoid regions within the force trace that may be associated with 165 
slow force development and anticipation to the decreasing force phase of the task, 8 s in the 166 
middle of the steady period of force maintenance was selected for data analysis. Standard 167 
deviation (SD) was used to quantify force variability in the task-related direction. Force error 168 
was calculated using the residual sum of squares error (RSS) of the force trace from the target 169 
line, reflecting the force accuracy in the Fz direction. The total excursion of the centre of 170 
pressure (CoP) was used to quantify lateral shifts of the quasi-static net force (i.e. changes in 171 
force direction). This index reflects the total length of the CoP path in a given time period
29
 and 172 
represents an indirect measure of the tangential force variation.
26,32,33
 A two-dimensional 173 
histogram of tangential force components was developed using a 5-by-5 equally spaced grid to 174 
represent the range of the force in the Fy (wrist radial-ulnar deviation) and Fx (longitudinal 175 
movement of the wrist) direction. Coordinates of the centroid were extracted from the force 176 
histogram. For the analysis of the effect of persistent pain, the centroid position at day-2 and at 177 
day-4 was subtracted from the position of the centroid obtained during baseline day-0 for both 178 
groups. For saline-induced muscle pain, centroid position during and after saline-induced pain 179 
was subtracted from the baseline (before saline-induced pain trial) at the same day (day-2). To 180 
provide a “no-pain” measure of the change in centroid position against which the hypertonic 181 
saline conditions could be compared, we subtracted the centroid position prior to saline induced 182 
pain on day-2 from the centroid position prior to isotonic saline injection on day-0, for the 183 
Control group. The absolute difference in Fy and Fx directions were extracted (Fy and Fx, 184 
respectively). A centroid position difference (Fx-CPD and Fy-CPD) value deviating from zero 185 
indicates that new combinations of tangential forces were used in that condition reflecting 186 
changes the direction of the net force.
15,25
 Thus, CoP quantifies variability of the force direction, 187 
whereas CPD represents magnitude of change in the direction of the force between two trials. 188 
 189 
Statistical analysis 190 
SD of the force (Fz) and excursion of the CoP were normalised for each injection type. To 191 
reduce the between-subject variability of the samples,
37
 normalisation was implemented by 192 
dividing parameters of each participant with their peak value across trials (Baseline day-0, 193 
Baseline day-2 [before saline-induced pain], and Baseline day-4 for NGF/isotonic saline 194 
injection; and before, during, and after saline-induced pain for hypertonic saline injection).  195 
Effects of saline-induced pain: To test the first hypothesis whether force variation in the 196 
tangential direction (excursion of CoP), and/or variation (SD of Fz) and error (Fz RSS) in the 197 
primary task direction were altered by saline-induced muscle pain on day-2, a repeated measures 198 
analysis of variance (ANOVA) was applied using Time (before, during, and after saline-induced 199 
muscle pain) as a within-subject factor for the Control group. This analysis did not include the 200 
NGF group who received saline injection in addition to NGF. To test whether force direction is 201 
altered by saline-induced pain on day-2, CPD were analysed using a repeated measures ANOVA 202 
with and Time (Baseline [pre-injection day-0 minus pre-injection day-2], during saline-induced 203 
pain [pre-pain minus pain], and after [post-pain minus pain]) as a within-subject factor.  204 
Effects of injection of NGF and isotonic saline: To test hypotheses 2 and 3, whether force 205 
direction variation (excursion of CoP), and/or variation (SD of Fz) and error (Fz RSS) in the 206 
primary task direction were modified after several days of sustained pain following NGF 207 
injections; these data were analysed using a mixed-model design ANOVA with Group (NGF and 208 
isotonic saline) as a between-subject factor, and Session (day-0, day-2 before-saline injection, 209 
and day-4) as a within-subject factor. To test whether tangential force direction is altered by 210 
persistent pain, CPD were analysed using a mixed-model ANOVA with Group (NGF and 211 
isotonic saline) as a between-subject factor and Session (day-2 before-saline injection minus pre-212 
injection day-0 and day-4 minus pre-injection day-0) as a within-subject factor. Newman–Keuls 213 
(NK) post-hoc tests were applied in case of significant effects from main factors or interactions. 214 
We also compared maximum force between sessions to investigate whether this was constant 215 
across days. 216 
Effects of saline-induced pain during persistent movement-evoked pain: To test hypothesis 217 
4, whether force variation in the force direction (excursion of CoP), and/or variation (SD of Fz) 218 
and error (Fz RSS) in the primary task direction were altered by saline-induced muscle pain 219 
during movement-evoked pain on day-2, a repeated measures analysis of variance (ANOVA) 220 
was applied using Time (before, during, and after saline-induced muscle pain) as a within-subject 221 
factor for the NGF group. CPD were analysed using a repeated measures ANOVA with Time 222 
(Baseline [pre-injection day-0 minus pre-injection day-2], during saline-induced pain [pre-pain 223 
minus pain], and after [post-pain minus pain]) as a within-subject factor.  224 
As peak VAS scores and data from the pain questionnaire were not normally distributed, 225 
Mann-Whitney U tests were used to assess differences between groups (before, during, and after 226 
saline-induced pain for peak VAS scores, and day-0, day-2, and day-4 for pain questionnaire 227 
measures, respectively). The Wilcoxon Signed Rank test was used to analyse for differences 228 
between sessions within a group across time trials (VAS scores) and days (pain questionnaire, 229 
measures were analysed individually), and Bonferroni corrections were used to adjust P-values 230 
for multiple comparisons. Data are presented as magnitude of relevant difference in the results 231 
section, and mean and standard error of the mean (SEM) throughout the text tables and figures. 232 
P-values less than 0.05 were regarded as significant. 233 
 234 
RESULTS 235 
Pain  236 
Participants injected with NGF reported greater NRS pain scores when performing “repeated arm 237 
movements” on day-2 (2.6/10) and day-4 (1.6/10) than those injected with isotonic saline (Table 238 
1, Z=3.3, P<0.001). The NGF group also reported greater “maximum pain experienced over the 239 
past 48 hours” on day-2 (2.7/10) and day-4 (2.1/10) than day-0 (Z=3.05, P<0.002), and the 240 
highest “maximum pain experienced over the past 48 hours” was reported on day-2 (0.9/10) 241 
(Z=3.17, P<0.001). There was no significant difference in NRS pain scores “at rest” between 242 
groups.  243 
The NGF group reported higher VAS scores before (1.04/10) and after (0.58/10) saline-244 
induced pain than the control group (Z=4.46, P<0.001), although these difference in the levels of 245 
pain might not be considered as clinically relevant. Both groups reported higher VAS scores 246 
during saline-induced pain than before and after saline-induced pain (6.23/10) (Table 2, Z=4.45, 247 
P<0.001). VAS scores did not differ between groups during saline-induced pain (Z=1.64, 248 
P=0.09). 249 
 250 
Effect of saline-induced pain (control group) 251 
Comparison of force between trials performed before, during, and after saline-induced pain on 252 
day-2 for the control group showed that variation was increased in the primary task-direction 253 
during acute pain (0.11/1) (SD of Fz; ANOVA: F(2,24)=3.52; P<0.05; NK: P<0.05) consistent 254 
with a decrease in motor performance during pain (Fig. 2A). Variation of the force direction was 255 
also Comparison of force between trials performed before, during, and after saline-induced pain 256 
on day-2 for the control group showed greater (0.18/1) variation in the force direction (CoP 257 
excursion; ANOVA: F(2,21)=4.44, P=0.023; NK: P<0.005) during acute pain compared with 258 
before and after trials (Fig. 2A). This shows that increased variation of force in directions other 259 
than the task-direction, which is consistent with a search for a new solution. Variation was also 260 
increased during acute pain in the primary task-direction (SD of Fz; ANOVA: F(2,24)=3.52; 261 
P<0.05; NK: P<0.05) consistent with pain (Fig. 2A). There was no significant difference in force 262 
error (Fz RSS) during saline-induced pain (ANOVA: F(2,22)=1.29; P>0.15; Fig. 2B) indicating 263 
that despite the increase in variation they could maintain the level of force. 264 
In the Control group, CPD in the Fy direction (wrist radial-ulnar deviation) during saline-265 
induced pain (contrast between measures made on day-2 during and before saline-induced pain) 266 
was greater than the contrast between measures made before injections on day-2 and day-0 (as an 267 
estimate of CPD expected between sessions in the absence of pain) and after saline-induced pain 268 
(contrast between measures made on day-2 after and before saline-induced pain) (0.28/5) 269 
(ANOVA: F(2,22)=9.35; P<0.001; NK: P<0.02; Fig. 3 and Table 3). This shows a greater change 270 
in force direction when challenged by saline-induced muscle pain than would be expected 271 
between sessions without pain.  272 
 273 
Effect of prolonged movement-evoked pain on the direction of the force 274 
CPD (contrast of measures made on day-2 before saline-induced pain and day-0, and the contrast 275 
between measures made on day-4 and day-0) in the Fy direction (wrist radial-ulnar deviation) 276 
was greater in the NGF than control group (0.12/5) (ANOVA: F(1,22)=4.26; P<0.05; NK: P<0.05; 277 
Fig. 3). This shows that persistent pain involves a new task “solution” as indicated by the 278 
modification of the combination of forces used to achieve the task goal.  279 
 280 
Effect of prolonged movement-evoked pain on the variation of the force 281 
Comparison of contraction force between trials performed before injection of NGF, day-2 282 
(before saline-induced pain), and day-4 showed no difference in variation in the primary task-283 
direction (SD of Fz; F2,42=1.87, P=0.15) and variation of the direction (CoP excursion; 284 
F1,42=1.11, P=0.30; Fig. 4A). This finding shows that there is no on-going increase in force 285 
variation (i.e. no on-going “search”) in the presence of persistent pain. The force error (Fz RSS) 286 
(ANOVA: F(1,22)=2.20; P=0.15; Fig. 4C) and the MVC in the task-related direction (ANOVA: 287 
F(2,22)=2.31; P=0.10; Fig. 4D) were not affected significantly by persistent movement-evoked 288 
pain, indicating that they could maintain the level of force despite the modified force direction. 289 
 290 
CPD (contrast of measures made on day-2 before saline-induced pain and day-0, and the 291 
contrast between measures made on day-4 and day-0) in the Fy direction (wrist radial-ulnar 292 
deviation) was greater in the NGF than control group (ANOVA: F(1,22)=4.26; P<0.05; NK: 293 
P<0.05; Fig. 3). This shows that persistent pain involves a new task “solution” as indicated by 294 
the modification of the combination of forces used to achieve the task goal. The force error (Fz 295 
RSS) (ANOVA: F(1,22)=2.20; P=0.15; Fig. 4C) and the MVC in the task-related direction 296 
(ANOVA: F(2,22)=2.31; P=0.10; Fig. 4D) were not affected significantly by persistent movement-297 
evoked pain, indicating that they could maintain the level of force despite the modified force 298 
direction. 299 
 300 
Effect of saline-induced acute pain during prolonged movement-evoked pain 301 
Similar to the control group, cComparison of contraction force for wrist extension performed 302 
before, during and after saline-induced pain on day-2 for the NGF group showed greater 303 
variation in the task-related direction (0.15/1) (SD of Fz; ANOVA: F(2,22)=4.42; P<0.05) and in 304 
the variation of the force direction (0.19/1) (CoP excursion; ANOVA: F(2,10)=11.10, P<0.005; 305 
NK: P<0.005) during acute pain.  306 
When saline-induced pain was added to the persistent movement-evoked related pain 307 
induced by NGF injection, the CPD in the Fy direction calculated using the contrast of measures 308 
made on day-2 during and day-2 before saline-induced pain (i.e. effect of saline induced pain) 309 
was greater than the contrast of day-2 before saline-induced pain and day-0 (i.e. effect of 310 
persistent pain) (0.25/5) (ANOVA: F(1,24)=13.55; P=0.001; NK: P=0.001). In the presence of 311 
persistent pain, participants retained the capacity to adapt in the same manner (increase variation 312 
in the force direction and change force direction) as participants who had no persistent pain. 313 
 314 
DISCUSSION  315 
These results show that saline-induced acute muscle pain increases variation in the task-related 316 
force and changes the variation and direction of the forces, but without affecting the ability to 317 
achieve the task goal. When people are assessed after a period of persistent pain the force 318 
direction differs from baseline, but with no difference in variation. These findings can be 319 
interpreted according to contemporary theories of motor adaptation and are likely to represent 320 
different elements of the search and then consolidation of a new, potentially more protective 321 
solution, while maintain the capacity to achieve the task goal. 322 
 323 
Pain during hypertonic saline and NGF injection 324 
The two pain models used in this study induced pain with different intensities, qualities and pain 325 
duration profiles. These were selected to study the impact of short-term acute pain and persistent 326 
movement-evoked pain on motor control strategies. Participants receiving NGF injections 327 
reported soreness and pain evoked by arm movement in the days following the injection, but not 328 
immediately after injection and minimal or no pain at rest (no spontaneous pain). Although the 329 
mechanism underlying the pain response following NGF injection remains unclear, it has been 330 
suggested to involve sensitization of nociceptors without inducing spontaneous discharge.
28,34
 331 
The intensity and duration of movement-evoked pain by administration of NGF provides a useful 332 
model to study effects of prolonged pain. Intramuscular injection of hypertonic saline induced 333 
spontaneous and transient muscle pain in both groups that lasted a few minutes. Saline-induced 334 
pain has been associated with robust excitation of the nociceptive afferent fibres
13,20
 but is not 335 
clearly related to movement/muscle activation.
40
 The lack of difference in the intensity of pain 336 
induced by hypertonic saline injection between groups has several interpretations. First, 337 
sensitisation of nociceptive neurons by NGF may not enhance their responsiveness to hypertonic 338 
saline. Second, that the hypertonic saline may not have excited the same population of 339 
nociceptive neurons that were sensitised by NGF (injection in a slightly different location). 340 
Comparable pain intensity has been reported during saline-induced pain between muscles with 341 
and without sensitisation by eccentric exercise.
11,36,45
 Similar results have been observed in 342 
glutamate-evoked pain in participants with and without injection of NGF in the masseter 343 
muscle.
39
 344 
 345 
Changes in isometric wrist extension force with pain 346 
Variation of the task-related and tangential force direction was increased during saline-induced 347 
muscle pain for both groups (i.e. irrespective of whether there was an underlying persistent pain). 348 
This concurs with previous findings of the effect of acute muscle pain on the force variation for 349 
isometric shoulder-abduction,
2
 elbow flexion,
25,32
 knee extension
31
, and dorsiflexion.
32
  350 
Increased variation in the task-related direction may represent a detrimental effect of pain 351 
mediated by several possible mechanisms. Experimental muscle pain decreases the ability of 352 
central nervous system to process proprioceptive information,
7
 and alters the population of 353 
recruited motor units,
9,41
 each of which may impact the capacity of the muscle to maintain 354 
constant force. It is important to note that although the quality of the motor tasks was 355 
compromise, they could still achieve the task goal (no change in task error). Although the 356 
increase in variation of the tangential direction may also represent a similar mechanism, it may 357 
also serve a purpose; to aid the search for a new less provocative solution (see below). 358 
NGF-induced muscle soreness (without the addition of hypertonic saline injection) was not 359 
associated with more force variation than baseline (day-0) when tested after pain had been 360 
experienced for 2 and 4 days. This implies that in this model of slowly increasing movement-361 
evoked pain there is either no change in variation or that there is an initial increased in variation, 362 
that resolves when pain is maintained. This latter possibility is consistent with previous findings 363 
demonstrating that force variability is only affected for a few hours after the onset of muscle 364 
soreness induced by eccentric exercise although maximal force is reduced for several days in that 365 
model.
21,35
 In such case the decrease in maximal force beyond 24 hours after eccentric exercise is 366 
most likely mediated by muscle fibre damage.
38
 Although it could be argued that soreness and 367 
movement-related pain following eccentric exercise might also be involved via effects of pain on 368 
motor output,
47
 the absence of decrement in MVC across days in the present study does not 369 
support this proposal. Taken together these findings support the hypothesis that muscle damage, 370 
but not soreness and movement-evoked pain, explain the diminished force after eccentric 371 
exercise.
29,38
 372 
Immediate motor adaptations to acute nociceptive input are task dependent,
5,17,25
 whereas 373 
the effects of persistent pain remain unclear. From our study it is not possible to determine 374 
whether soreness and movement-evoked pain induced by NGF was associated with greater 375 
variation of the forces in the primary task direction or tangential directions at the onset of pain 376 
provocation as participants were not tested until 2 days after the injection. Despite this, the data 377 
show convincing evidence of isometric wrist extension with different direction of tangential 378 
forces, but with unchanged variation in force in any direction, after several days with pain. This 379 
corroborates the hypothesis that motor adaptations are consolidated over time, that is, although 380 
an initial increase in variation may have facilitated a search for a new solution, when pain is 381 
persistent and a new solution is identified, variation returns to baseline levels. Changes in the 382 
force direction during experimental pain has been found in previous studies
32,42
 and it has been 383 
suggested that this strategy aims to reduce pain further and potential tissue damage.
17,42
 Even 384 
slight altered direction of the force represents a great impact on the efficiency of the mechanical 385 
system during pain.
42
 386 
 387 
Factors involved in the consolidation of motor adaptations over time 388 
The motor system enables people to perform daily activities using pre-learned motor strategies, 389 
acquired by repetition, failure and success in previous experiences.
3
 Using fMRI, it has been 390 
shown that the extent of cortical activation increases in healthy subjects when learning an 391 
untrained motor skill for 2 weeks
44
 and then decreases with further training. This adaptation is 392 
thought to relate to the initial exploration and heightened attention to perform the new task 393 
during training, followed by the consolidation of a new strategy. Thus, the motor system need to 394 
explore for a strategy that satisfies the new requirements, and increasing the tangential force 395 
variation may facilitate the searching in acute pain.
27
 396 
High precision force-matching tasks are an unfamiliar motor activity, and most likely 397 
require participants to focus their attention during performance. Results from chronic pain 398 
patients have shown that those who report high pain intensities have reduced attention when 399 
performing complex motor tasks than those with low pain and controls.
8
 Distraction due to high-400 
pain intensity could account for the increased variation in the force during saline-induced pain.  401 
Motor adaptations induced by soreness and movement-evoked pain lasted for several days. 402 
The adaptations caused by persistent pain are observed as reorganisation of the tangential force 403 
to perform the motor task sustained across days. There was a non-significant tendency for greater 404 
changes in the tangential force combination at day 4 than day 2, even though peak soreness and 405 
pain were reported at day 2. This means that participants who received NGF injection continued 406 
to display protective behaviours even when persistent pain had begun to resolve. It has been 407 
suggested that the anticipation to experience pain, rather than pain itself, might account for the 408 
sustained pain adaptations in chronic pain patients.
10
 Moreover, pain has been described as a 409 
“motivator” for motor adaptation, but pain cessation does not necessarily motivate a return to the 410 
pre-pain pattern.
17
 Whether the force recovered after the resolution of the sustained pain was not 411 
studied in this experiment, but should be considered in future work. 412 
There is debate whether pain interferes with learning a motor skill. Although some data 413 
show reduced adaptation of cortical excitability during learning in the presence of pain,
6
 when 414 
the quality of practice of the task is controlled, there is no interference.
19
 Thus, pain may not 415 
compromise learning, but appears to lead to the learning of a different task such as an adaptation 416 
to alter the motor strategy used to achieve the goal of the motor task during pain.
17
 The present 417 
results showed that participants with persistent pain retained the new strategy (potentially a 418 
protective behaviour) across sessions. It has been shown that supplementary motor areas are 419 
associated with the programing of the motor sequence, whereas the primary motor cortex is 420 
involved with the execution of the motor tasks.
31
 This could clarify why subjects reported pain 421 
and reduced function of the NGF-injected ECRB muscle 2 days before significant primary motor 422 
cortex reorganisation was found.
37
 Taken together this implies that early changes induced by 423 
hypertonic saline injection and the retention of adapted motor strategies after NGF induced pain 424 
may involve different brain regions. 425 
Interpretation of the present findings requires consideration of several limitations. First, the 426 
current findings are limited to steady force control during low level of isometric wrist extensions, 427 
and do not necessarily generalize to other types of contractions relevant to functional activities, 428 
such as, for example, dynamic force control during concentric/eccentric contractions or higher 429 
level of contractions. Second, the data was collected in confined time intervals and the motor 430 
adaptations were not constantly monitored following NGF injection, so learning and 431 
consolidation of a new motor strategy is assumed from the results. However, because of the 432 
specificity of the assessed motor task and for practical reasons, it was not possible to perform a 433 
continuous assessment of the motor task. Therefore, changes in the movement pattern for daily 434 
activities at times between the data collection sessions, including isometric wrist extensions, 435 
remain unknown. Third, changes in the arm position between trials might affect the CoP, 436 
although SD Fz and CPD indexes are not affected by the reposition of the arm. To reduce this 437 
error, participants’ wrist was marked facilitating the same position between trials. Fourth, the 438 
number of female participants was not balanced between groups. A previous study showed no 439 
gender difference in NGF evoked sensitization, although hypertonic saline superimposed to NGF 440 
elicited higher pain in males than females.
1
 Gender comparison between groups during 441 
hypertonic saline was not performed and it was beyond the scope of this study because of the 442 
sample size.  443 
CONCLUSION 444 
Acute pain increases force variation and changes the force direction, but when pain is sustained 445 
only the force direction differs from that in a pain-free state. These differences imply different 446 
elements of learning a new motor strategy in the presence of pain; an initial “search” for a 447 
beneficial solution mediated by increased variation, and a later “consolidation” to the new 448 
alternative. In a clinical context if pain is sustained, treatments that target pain relief might 449 
require additional intervention that targets changes in motor performance to restore the pain-free 450 
optimal control of the task.   451 
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  577 
FIGURE LEGENDS 578 
 579 
Fig. 1. Experimental setup and protocol. Upper panel: Wrist extension force was recorded in the 580 
task-related (Z) and the tangential (X and Y) directions using a three-dimensional force 581 
transducer. Marks on the wrist and on the force transducer were used to replace the arm in the 582 
same position at each session. Lower panel: Time-course of the experimental protocol. On day-0, 583 
the extensor carpi radialis brevis muscle (dominant arm) of twenty-six healthy volunteers was 584 
injected with nerve growth factor (NGF, N=13) or isotonic saline (ISO, N=13). On day-2, acute 585 
experimental muscle pain was induced by injection of hypertonic saline into the extensor carpi 586 
radialis brevis muscle (same side as the first injection) of all participants. 587 
 588 
Fig. 2. Normalised mean (±SEM, N=13) (A) standard deviation (SD) of task-related force and 589 
(B) excursion of the centre of pressure for tangential forces (CoP) during the steady contraction 590 
period (wrist extension at 10% maximal voluntary contraction force) for saline-induced pain. 591 
Significantly increased during saline-induced pain compared with before and after saline-induced 592 
pain sessions (*, P<0.05). (C) Normalised mean (±SEM, N=13) residual sum of squares error 593 
(RSS) in the task-related (Fz) direction before, during, and after saline-induced pain. 594 
 595 
Fig. 3. Distribution of centroid position difference (CPD) of the tangential forces (Fx and Fy). 596 
Data are shown for the Control group in the absence of pain (contrast between baseline day-0 597 
and baseline day-2; far left, upper panel) and for the NGF group after 2 days of pain (contrast 598 
between measures before NGF injection on day-0 and before saline injection day 2; far left, 599 
lower panel). Subsequent panels show CPD for both groups during and after saline-induced pain 600 
(contrasted to before saline-induced pain) on day-2, and on day-4 (contrast between baseline 601 
day-0 and day-4; far right panel). Both groups showed greater CPD (spread of the colours) in the 602 
Fy direction (P<0.001) when challenged with saline-induced pain compared with the baseline 603 
condition. This reflects greater changes in the direction of tangential force used to achieve the 604 
motor task. The NGF group showed greater CPD than the control group across days in the Fy 605 
direction (P<0.05), i.e. NGF group deviate from the baseline direction of tangential force across 606 
days. 607 
 608 
Fig. 4. Normalised mean (±SEM, N=13) (A) standard deviation (SD) of task-related force and 609 
(B) excursion of the centre of pressure for tangential forces (CoP) during the steady contraction 610 
period (wrist extension at 10% MVC force) across days (day-0, baseline day-2, day-4) for 611 
persistent movement-evoked pain (NGF) and controls. (C) Normalised mean (±SEM, N=13) 612 
residual sum of squares error (RSS) in the task-related (Fz) direction. (D) Maximal voluntary 613 
contraction (MVC) force in the task-related direction (Fz) across days. 614 
 615 
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